586 related articles for article (PubMed ID: 32700510)
1. [Characteristics of SARS-CoV-2 and potential pharmacological treatment].
Pawlik L; Śpiołek E; Fichna J; Tarasiuk A
Postepy Biochem; 2020 May; 66(2):83-90. PubMed ID: 32700510
[TBL] [Abstract][Full Text] [Related]
2. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China.
Awadasseid A; Wu Y; Tanaka Y; Zhang W
Int J Biol Sci; 2020; 16(11):1846-1860. PubMed ID: 32398954
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
Sharma A; Tiwari S; Deb MK; Marty JL
Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
[TBL] [Abstract][Full Text] [Related]
4. The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing.
MacKay MJ; Hooker AC; Afshinnekoo E; Salit M; Kelly J; Feldstein JV; Haft N; Schenkel D; Nambi S; Cai Y; Zhang F; Church G; Dai J; Wang CL; Levy S; Huber J; Ji HP; Kriegel A; Wyllie AL; Mason CE
Nat Biotechnol; 2020 Sep; 38(9):1021-1024. PubMed ID: 32820257
[No Abstract] [Full Text] [Related]
5. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
Li YC; Bai WZ; Hashikawa T
J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
[TBL] [Abstract][Full Text] [Related]
7. Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.
Zhang T; Cui X; Zhao X; Wang J; Zheng J; Zheng G; Guo W; Cai C; He S; Xu Y
J Med Virol; 2020 Jul; 92(7):909-914. PubMed ID: 32222992
[TBL] [Abstract][Full Text] [Related]
8. Doubling Time of the COVID-19 Epidemic by Province, China.
Muniz-Rodriguez K; Chowell G; Cheung CH; Jia D; Lai PY; Lee Y; Liu M; Ofori SK; Roosa KM; Simonsen L; Viboud C; Fung IC
Emerg Infect Dis; 2020 Aug; 26(8):1912-1914. PubMed ID: 32330410
[TBL] [Abstract][Full Text] [Related]
9. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.
Tahmasebi S; Khosh E; Esmaeilzadeh A
J Cell Physiol; 2020 Dec; 235(12):9211-9229. PubMed ID: 32452050
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2.
Song M; Li ZL; Zhou YJ; Tian G; Ye T; Zeng ZR; Deng J; Wan H; Li Q; Liu JB
J Zhejiang Univ Sci B; 2020 Sept.; 21(9):749-751. PubMed ID: 32893532
[TBL] [Abstract][Full Text] [Related]
11. From SARS to COVID-19: What lessons have we learned?
Liu Q; Xu K; Wang X; Wang W
J Infect Public Health; 2020 Nov; 13(11):1611-1618. PubMed ID: 32888871
[TBL] [Abstract][Full Text] [Related]
12. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
14. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
[TBL] [Abstract][Full Text] [Related]
15. HIV and SARS-CoV-2: points to consider to face this new pandemic.
Prieto Pozo AA; Salvador Sagüez FLD
Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
[TBL] [Abstract][Full Text] [Related]
16. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
McAdam AJ
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
[No Abstract] [Full Text] [Related]
17. The establishment of reference sequence for SARS-CoV-2 and variation analysis.
Wang C; Liu Z; Chen Z; Huang X; Xu M; He T; Zhang Z
J Med Virol; 2020 Jun; 92(6):667-674. PubMed ID: 32167180
[TBL] [Abstract][Full Text] [Related]
18. Understanding COVID-19: From Origin to Potential Therapeutics.
Moazzam M; Sajid MI; Shahid H; Butt J; Bashir I; Jamshaid M; Shirazi AN; Tiwari RK
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32823901
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
Trials; 2020 May; 21(1):422. PubMed ID: 32448345
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology and clinical information about COVID-19.
Ge H; Wang X; Yuan X; Xiao G; Wang C; Deng T; Yuan Q; Xiao X
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1011-1019. PubMed ID: 32291542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
